Latest On Neoleukin Therapeutics, Inc (NLTX):
About Neoleukin Therapeutics, Inc (NLTX):
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
General
- Name Neoleukin Therapeutics, Inc
- Symbol NLTX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 65
- Fiscal Year EndDecember
- IPO Date2014-03-07
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.neoleukin.com
Valuation
- Price/Book (Most Recent Quarter) 2.62
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.29
- Return on Assets -16%
- Return on Equity -22%
- Earnings Per Share -$0.94
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 486.02 million
- Analyst Target Price $22
- Book Value Per Share $2.38
Share Statistics
- Shares Outstanding 41.93 million
- Shares Float 21.3 million
- % Held by Insiders 2029%
- % Held by Institutions 66.22%
- Shares Short 2.98 million
- Shares Short Prior Month 3.22 million
- Short Ratio 13.68
- Short % of Float 8%
- Short % of Shares Outstanding 7%
Technicals
- Beta 0.99
- 52 Week High $18.13
- 52 Week Low $7.1
- 50 Day Moving Average 12.55
- 200 Day Moving Average 12.52
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Neoleukin Therapeutics, Inc (NLTX) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Neoleukin Therapeutics, Inc (NLTX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-09 | $N/A | -$0.04 | -$0.23 | 82.46% |
2020-06-30 | 2020-08-12 | $N/A | -$0.20 | -$0.16 | -23.46% |
2020-03-31 | 2020-05-06 | $N/A | -$0.18 | -$0.24 | 23.73% |
2019-12-31 | 2020-03-12 | $N/A | -$0.23 | -$0.37 | 37.84% |
2019-09-30 | 2019-11-13 | $N/A | -$0.44 | -$0.04 | -990% |
2019-06-30 | 2019-08-01 | $N/A | $0.00 | -$0.05 | 100% |
2019-03-31 | 2019-05-07 | $N/A | -$0.09 | -$0.23 | 60.87% |
2018-12-31 | 2019-03-07 | $N/A | -$0.20 | -$0.79 | 74.68% |
2018-09-30 | 2018-11-07 | $N/A | -$0.64 | -$0.21 | -204.76% |
2018-06-30 | 2018-08-08 | $25 million | $0.12 | -$0.59 | 120.34% |
2018-03-31 | 2018-05-08 | $N/A | -$0.62 | -$0.71 | 12.06% |
2017-12-31 | 2018-03-12 | $N/A | -$0.69 | -$0.60 | -15% |
2017-09-30 | 2017-11-08 | $N/A | -$0.50 | -$0.59 | 14.89% |
2017-06-30 | 2017-08-08 | $N/A | -$0.59 | -$0.51 | -15.12% |
2017-03-31 | 2017-05-09 | $N/A | -$0.36 | -$0.51 | 29.76% |
2016-12-31 | 2017-03-09 | $N/A | -$0.48 | -$0.46 | -4.35% |
2016-09-30 | 2016-11-09 | $N/A | -$0.46 | -$0.58 | 21.03% |
2016-06-30 | 2016-08-04 | $N/A | -$0.63 | -$0.39 | -61.54% |
2016-03-31 | 2016-05-10 | $N/A | -$0.39 | -$0.35 | -12.23% |
2015-12-31 | 2016-03-14 | $N/A | -$0.26 | -$0.36 | 26.76% |
2015-09-30 | 2015-11-10 | $N/A | -$0.43 | -$0.45 | 4.44% |
2015-06-30 | 2015-08-06 | $N/A | -$0.44 | -$0.56 | 21.43% |
2015-03-31 | 2015-05-12 | $N/A | -$0.60 | -$0.81 | 25.93% |
2014-12-31 | 2015-03-16 | -$0.78 | -$0.76 | -2.63% | |
2014-09-30 | 2014-11-04 | $N/A | -$0.59 | -$0.45 | -31.11% |
2014-06-30 | 2014-08-11 | $N/A | -$0.51 | -$0.27 | -88.89% |
2014-03-31 | 2014-05-13 | $N/A | -$1.28 | -$0.44 | -190.91% |
Neoleukin Therapeutics, Inc (NLTX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Neoleukin Therapeutics, Inc (NLTX) Chart:
Neoleukin Therapeutics, Inc (NLTX) News:
Below you will find a list of latest news for Neoleukin Therapeutics, Inc (NLTX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Neoleukin Therapeutics, Inc (NLTX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-07-19 | 2.5 | 0 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
2024-07-19 | 5 | 0 | CALL | 0 | 2 | 183.57 | FALSE | 0 | 0 |
2024-07-19 | 7.5 | 0 | CALL | 0 | 0 | 206.52 | FALSE | 0 | 0 |
2024-07-19 | 2.5 | 0 | PUT | 0 | 0 | 262.6 | TRUE | 0 | 0 |
2024-07-19 | 5 | 0 | PUT | 0 | 0 | 125.52 | TRUE | 0 | 0 |
2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 109.2 | TRUE | 0 | 0 |
Latest NLTX Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 38 | $0.9686 |
Jun 13, 2022 7:59 PM EST | 17 | $0.9686 |
Jun 13, 2022 7:59 PM EST | 59 | $0.9672 |
Jun 13, 2022 7:59 PM EST | 38 | $0.9672 |
Jun 13, 2022 7:59 PM EST | 10 | $0.9672 |
Neoleukin Therapeutics, Inc (NLTX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520186835/0001193125-20-186835-index.htm |
2018-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000003877718000043/0000038777-18-000043-index.htm |
2019-01-25 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000003877719000011/0000038777-19-000011-index.htm |
2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000008025518002567/0000080255-18-002567-index.htm |
2018-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000008025518002782/0000080255-18-002782-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000008025519002663/0000080255-19-002663-index.htm |
2018-01-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000021545718000086/0000215457-18-000086-index.htm |
2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319022733/0000899243-19-022733-index.htm |
2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/0000899243-19-023329-index.htm |
2019-09-13 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319023581/0000899243-19-023581-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319025571/0000899243-19-025571-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319025572/0000899243-19-025572-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319025573/0000899243-19-025573-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319025575/0000899243-19-025575-index.htm |
2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/0000899243-19-029824-index.htm |
2018-07-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000093583618000408/0000935836-18-000408-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000093583619000119/0000935836-19-000119-index.htm |
2019-12-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000093583619000673/0000935836-19-000673-index.htm |
2019-11-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1404644/000110465919065138/0001104659-19-065138-index.htm |
2019-12-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1404644/000110465919075093/0001104659-19-075093-index.htm |
2020-04-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043861/0001104659-20-043861-index.htm |
2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000114420418009001/0001144204-18-009001-index.htm |
2019-08-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1404644/000114420419038249/0001144204-19-038249-index.htm |
2019-08-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1404644/000114420419039617/0001144204-19-039617-index.htm |
2017-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312517336565/0001193125-17-336565-index.htm |
2017-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312517336569/0001193125-17-336569-index.htm |
2017-12-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312517370193/0001193125-17-370193-index.htm |
2018-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518004980/0001193125-18-004980-index.htm |
2018-02-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518037145/0001193125-18-037145-index.htm |
2018-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1404644/000119312518079210/0001193125-18-079210-index.htm |
2018-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518079220/0001193125-18-079220-index.htm |
2018-03-12 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1404644/000119312518079227/0001193125-18-079227-index.htm |
2018-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1404644/000119312518079240/0001193125-18-079240-index.htm |
2018-03-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1404644/000119312518095204/0001193125-18-095204-index.htm |
2018-03-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1404644/000119312518095207/0001193125-18-095207-index.htm |
2018-04-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1404644/000119312518107649/0001193125-18-107649-index.htm |
2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518155357/0001193125-18-155357-index.htm |
2018-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312518155359/0001193125-18-155359-index.htm |
2018-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518158253/0001193125-18-158253-index.htm |
2018-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518159868/0001193125-18-159868-index.htm |
2018-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518188804/0001193125-18-188804-index.htm |
2018-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518204812/0001193125-18-204812-index.htm |
2018-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518214778/0001193125-18-214778-index.htm |
2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312518242081/0001193125-18-242081-index.htm |
2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518242083/0001193125-18-242083-index.htm |
2018-09-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518269260/0001193125-18-269260-index.htm |
2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312518320293/0001193125-18-320293-index.htm |
2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312518320304/0001193125-18-320304-index.htm |
2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519066506/0001193125-19-066506-index.htm |
2019-04-15 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519106596/0001193125-19-106596-index.htm |
2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519139021/0001193125-19-139021-index.htm |
2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519209916/0001193125-19-209916-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519213526/0001193125-19-213526-index.htm |
2019-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519218513/0001193125-19-218513-index.htm |
2019-09-20 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1404644/000119312519250120/0001193125-19-250120-index.htm |
2019-10-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1404644/000119312519260378/0001193125-19-260378-index.htm |
2019-10-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1404644/000119312519260380/0001193125-19-260380-index.htm |
2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519260762/0001193125-19-260762-index.htm |
2019-10-11 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519266322/0001193125-19-266322-index.htm |
2019-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519290610/0001193125-19-290610-index.htm |
2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519290613/0001193125-19-290613-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519292399/0001193125-19-292399-index.htm |
2019-11-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1404644/000119312519293455/0001193125-19-293455-index.htm |
2019-12-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519306819/0001193125-19-306819-index.htm |
2019-12-17 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519316287/0001193125-19-316287-index.htm |
2019-12-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519316290/0001193125-19-316290-index.htm |
2019-12-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312519317636/0001193125-19-317636-index.htm |
2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519317938/0001193125-19-317938-index.htm |
2019-12-27 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1404644/000119312519324905/0001193125-19-324905-index.htm |
2019-12-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312519326026/0001193125-19-326026-index.htm |
2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520005970/0001193125-20-005970-index.htm |
2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000119312520035504/0001193125-20-035504-index.htm |
2020-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000119312520035513/0001193125-20-035513-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1404644/000119312520038492/0001193125-20-038492-index.htm |
2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520047316/0001193125-20-047316-index.htm |
2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520067891/0001193125-20-067891-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520071537/0001193125-20-071537-index.htm |
2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1404644/000119312520071545/0001193125-20-071545-index.htm |
2020-03-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1404644/000119312520071627/0001193125-20-071627-index.htm |
2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520080642/0001193125-20-080642-index.htm |
2020-03-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1404644/000119312520083231/0001193125-20-083231-index.htm |
2020-03-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1404644/000119312520083232/0001193125-20-083232-index.htm |
2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520104856/0001193125-20-104856-index.htm |
2020-04-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1404644/000119312520109381/0001193125-20-109381-index.htm |
2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520109503/0001193125-20-109503-index.htm |
2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520156617/0001193125-20-156617-index.htm |
2020-07-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312520185196/0001193125-20-185196-index.htm |
2020-07-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1404644/000119312520186822/0001193125-20-186822-index.htm |
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520186835/0001193125-20-186835-index.htm |
2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520208195/0001193125-20-208195-index.htm |
2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000119312520242679/0001193125-20-242679-index.htm |
2018-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118019255/0001209191-18-019255-index.htm |
2018-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118019256/0001209191-18-019256-index.htm |
2018-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118019258/0001209191-18-019258-index.htm |
2018-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118019259/0001209191-18-019259-index.htm |
2018-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118019260/0001209191-18-019260-index.htm |
2018-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118019267/0001209191-18-019267-index.htm |
2018-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118020680/0001209191-18-020680-index.htm |
2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118028968/0001209191-18-028968-index.htm |
2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118028974/0001209191-18-028974-index.htm |
2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118028979/0001209191-18-028979-index.htm |
2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118028983/0001209191-18-028983-index.htm |
2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118028988/0001209191-18-028988-index.htm |
2018-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118030711/0001209191-18-030711-index.htm |
2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118046094/0001209191-18-046094-index.htm |
2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118046095/0001209191-18-046095-index.htm |
2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118046097/0001209191-18-046097-index.htm |
2018-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919118046098/0001209191-18-046098-index.htm |
2020-03-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120019429/0001209191-20-019429-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120019430/0001209191-20-019430-index.htm |
2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120027679/0001209191-20-027679-index.htm |
2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120027683/0001209191-20-027683-index.htm |
2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120027689/0001209191-20-027689-index.htm |
2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120027694/0001209191-20-027694-index.htm |
2020-06-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120033538/0001209191-20-033538-index.htm |
2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120033543/0001209191-20-033543-index.htm |
2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120046339/0001209191-20-046339-index.htm |
2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120046342/0001209191-20-046342-index.htm |
2020-09-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120049960/0001209191-20-049960-index.htm |
2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120049966/0001209191-20-049966-index.htm |
2020-10-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120055394/0001209191-20-055394-index.htm |
2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000120919120055395/0001209191-20-055395-index.htm |
2019-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000121390019015382/0001213900-19-015382-index.htm |
2019-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000121390019015385/0001213900-19-015385-index.htm |
2019-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000121390019015387/0001213900-19-015387-index.htm |
2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000121390019015390/0001213900-19-015390-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000156459020021546/0001564590-20-021546-index.htm |
2020-05-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1404644/000156459020021550/0001564590-20-021550-index.htm |
2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000156459020021903/0001564590-20-021903-index.htm |
2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000156459020021920/0001564590-20-021920-index.htm |
2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1404644/000156459020039662/0001564590-20-039662-index.htm |
2020-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1404644/000156459020039671/0001564590-20-039671-index.htm |
2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000163859918000485/0001638599-18-000485-index.htm |
2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000803/0001638599-19-000803-index.htm |
2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000919/0001638599-19-000919-index.htm |
2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm |
2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1404644/000163859920000417/0001638599-20-000417-index.htm |
2018-04-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1404644/999999999518000773/9999999995-18-000773-index.htm |
2018-08-31 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1404644/999999999718007549/9999999997-18-007549-index.htm |
Neoleukin Therapeutics, Inc (NLTX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neoleukin Therapeutics, Inc (NLTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2029%Institutional Ownership: 6622%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-05-14 | DANIEL J LEVITT | Director | Sell | 3,906.00 | 12.67 | 49,489.02 | 0.00 | https://www.sec.gov/Archives/edgar/data/1404644/000120919118030711/0001209191-18-030711-index.htm |
2018-03-15 | Lloyd MacKenzie | Chief Operating Officer | Sell | 1,302.00 | 14.63 | 19,048.78 | 0.00 | https://www.sec.gov/Archives/edgar/data/1404644/000120919118020680/0001209191-18-020680-index.htm |
2019-08-07 | BROS. ADVISORS LP BAKER | Director | Buy | 209,382.00 | 3.02 | 633,254.92 | 10,054,723.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-07 | BROS. ADVISORS LP BAKER | Director | Buy | 50,436.00 | 3.15 | 159,019.66 | 10,105,159.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-06 | BROS. ADVISORS LP BAKER | Director | Buy | 855.00 | 2.83 | 2,422.04 | 1,170,550.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-06 | BROS. ADVISORS LP BAKER | Director | Buy | 5,932.00 | 2.85 | 16,887.81 | 1,176,482.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-07 | BROS. ADVISORS LP BAKER | Director | Buy | 531.00 | 2.96 | 1,570.49 | 1,177,013.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-07 | BROS. ADVISORS LP BAKER | Director | Buy | 18,943.00 | 3.02 | 57,291.21 | 1,195,956.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-07 | BROS. ADVISORS LP BAKER | Director | Buy | 4,564.00 | 3.15 | 14,389.84 | 1,200,520.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-12-20 | BROS. ADVISORS LP BAKER | Director | Buy | 2,767,505.00 | 8.40 | 23,247,042.00 | 12,872,664.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm |
2018-03-15 | Lloyd MacKenzie | Chief Operating Officer | Buy | 1,302.00 | 10.56 | 13,749.12 | 1,302.00 | https://www.sec.gov/Archives/edgar/data/1404644/000120919118020680/0001209191-18-020680-index.htm |
2019-12-20 | BROS. ADVISORS LP BAKER | Director | Buy | 250,037.00 | 8.40 | 2,100,310.80 | 1,450,557.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm |
2019-12-20 | JONATHAN G DRACHMAN | President and CEO | Buy | 119,047.00 | 8.40 | 999,994.80 | 2,198,686.00 | https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/0000899243-19-029824-index.htm |
2019-12-20 | BROS. ADVISORS LP BAKER | Director | Sell | 1,160,148.00 | 290,409.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm | ||
2019-12-20 | BROS. ADVISORS LP BAKER | Director | Sell | 9,765,333.00 | 3,107,331.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm | ||
2019-08-08 | JONATHAN G DRACHMAN | President and CEO | Buy | 334,428.00 | 334,428.00 | https://www.sec.gov/Archives/edgar/data/1404644/000121390019015390/0001213900-19-015390-index.htm | ||
2018-05-14 | DANIEL J LEVITT | Director | Buy | 3,906.00 | 10.56 | 41,247.36 | 3,906.00 | https://www.sec.gov/Archives/edgar/data/1404644/000120919118030711/0001209191-18-030711-index.htm |
2020-03-27 | Redmile Group, LLC | 10% Share Holder | Buy | 50,000.00 | 9.21 | 460,395.00 | 3,916,579.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-03-30 | Redmile Group, LLC | 10% Share Holder | Buy | 29,800.00 | 9.91 | 295,169.00 | 3,946,379.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-03-30 | Redmile Group, LLC | 10% Share Holder | Buy | 2,700.00 | 10.27 | 27,740.88 | 3,949,079.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-03-31 | Redmile Group, LLC | 10% Share Holder | Buy | 22,500.00 | 10.18 | 229,079.25 | 3,971,579.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-03-31 | Redmile Group, LLC | 10% Share Holder | Buy | 7,500.00 | 10.71 | 80,309.25 | 3,979,079.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-01 | Redmile Group, LLC | 10% Share Holder | Sell | 200.00 | 11.87 | 2,373.00 | 4,011,745.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-01 | Redmile Group, LLC | 10% Share Holder | Sell | 9,634.00 | 11.06 | 106,567.45 | 4,011,945.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-01 | Redmile Group, LLC | 10% Share Holder | Buy | 33,500.00 | 10.95 | 366,764.70 | 4,012,579.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-01 | Redmile Group, LLC | 10% Share Holder | Buy | 9,000.00 | 11.65 | 104,865.30 | 4,021,579.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-02 | Redmile Group, LLC | 10% Share Holder | Sell | 100.00 | 11.82 | 1,182.00 | 4,041,211.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-02 | Redmile Group, LLC | 10% Share Holder | Sell | 9,734.00 | 11.30 | 110,032.16 | 4,041,311.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-02 | Redmile Group, LLC | 10% Share Holder | Buy | 38,300.00 | 11.36 | 435,107.15 | 4,050,045.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2020-04-02 | Redmile Group, LLC | 10% Share Holder | Buy | 1,000.00 | 11.85 | 11,850.60 | 4,051,045.00 | https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm |
2019-09-09 | JONATHAN G DRACHMAN | Officer | Buy | 76,822.00 | 2.85 | 218,558.59 | 411,250.00 | https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/0000899243-19-023329-index.htm |
2019-09-10 | JONATHAN G DRACHMAN | Officer | Buy | 36,742.00 | 3.08 | 113,290.28 | 447,992.00 | https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/0000899243-19-023329-index.htm |
2019-09-11 | JONATHAN G DRACHMAN | Officer | Buy | 136,436.00 | 3.30 | 449,897.71 | 584,428.00 | https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/0000899243-19-023329-index.htm |
2019-08-08 | JONATHAN G DRACHMAN | President and CEO | Buy | 7,428.00 | 7,428.00 | https://www.sec.gov/Archives/edgar/data/1404644/000121390019015390/0001213900-19-015390-index.htm | ||
2019-08-06 | BROS. ADVISORS LP BAKER | Director | Buy | 9,445.00 | 2.83 | 26,755.80 | 9,773,904.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-06 | BROS. ADVISORS LP BAKER | Director | Buy | 65,568.00 | 2.85 | 186,665.54 | 9,839,472.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |
2019-08-07 | BROS. ADVISORS LP BAKER | Director | Buy | 5,869.00 | 2.96 | 17,358.15 | 9,845,341.00 | https://www.sec.gov/Archives/edgar/data/1404644/000163859919000703/0001638599-19-000703-index.htm |